Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study - EClinicalMedicine #ATMSC
THREAD: Did scientists find “Moderna-patented DNA” inside the Covid virus?
Short answer: No — and here’s why the headline is misleading. [It does get suckers to click and share and that creates REVENUE for the Mail.]
1/ A viral headline claims scientists found a “DNA sequence patented by Moderna” inside SARS-CoV-2, implying the virus was engineered in a lab.
That sounds dramatic — but it’s not true. And here’s the science behind it.
2/ First: SARS-CoV-2 is an RNA virus.
It does not contain DNA.
So any claim that “DNA was found inside the virus” is already biologically off-base.
What the headline refers to is not DNA in the virus — just a short nucleotide sequence.
(1/) A video I replied to claims LASIK is cheap because it’s not government-controlled but “free market,” while insured surgery costs more because of “government” and “socialized medicine.” This sounds clever, but it’s deeply wrong.
Here’s why the comparison is bogus, step by step.
(2/) LASIK isn’t cheap because it’s a “pure market.” It’s cheap because it’s simple, standardized, and elective.
• One narrow procedure
• Low risk, short duration
• No hospitalization/ICU
• Predictable outcomes
That makes it easy to streamline and compete on price.
@LibertyCappy LASIK is a narrow, elective service in a highly controlled market. Real healthcare has to handle the entire messy reality of human illness — emergency, chronic, unpredictable, & life-saving.
Govt. doesn’t cause high costs — unregulated private complexity and profiteering do.
@LibertyCappy LASIK isn’t cheap because it’s “free market.” It’s cheap because it’s simple, standardized, & elective.
Single, low-risk procedure: LASIK is a routine, outpatient surgery done under local anesthesia. No hospital stay, minimal risk, and the same few tools used thousands of times.
@LibertyCappy Cash-based, not insurance-based: Because everyone pays out of pocket, clinics compete directly on price and marketing. There’s a limited range of services and few surprises.
@DCVaxDefender 1/
Excellent thread. The post correctly reframes how we think about #Flaskworks and #NWBO's model for autologous cell therapy.
Here’s a short thread affirming the key points—and adding current confirmation of the UK’s regulatory position.
@DCVaxDefender 2/
First: yes, Flaskworks is not “decentralised” in the point-of-care sense. It’s not about moving production into hospitals. It’s a centralised, industrial platform for parallelised autologous manufacturing at scale.
@DCVaxDefender 3/
The GPU vs. CPU analogy is spot on.
Old model: sequential, manual, cleanroom-heavy.
Flaskworks: single instruction, multiple patient-specific batches, executed in parallel under unified GMP oversight.
It’s not fragmentation—it’s consolidation with scale.
Not your fault. But taxation without Representation was what got this entire experiment in democracy going. Presidents have some powers re Tariffs but not the complete and total powers required for this executive order. For heaven’s sake, make noise!
Despite being in the mi purity, you need to be speaking loudly and doing everything possible to both stop the tariffs legally, and embarrass the GOP into asserting Congressional Authority over the purse strings and Tariffs.
We do NOT have a KING and we NEVER WILL have a KING!